Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents. The Epoxy segment provides Allylics, such as allyl chloride, epichlorohydrin, and glycerin; aromatics, including acetone, bisphenol, cumene, and phenol; liquid and solid epoxy resins; and converted epoxy resins and additives. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, gun clubs, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.

Olin Corporation

Bernstein analyst Pujarini Ghosh maintained a Buy rating on Holcim yesterday. The company’s shares closed last Wednesday at CHF72.38. According to ...

Bernstein Keeps Their Buy Rating on Holcim (0QKY)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molecular Partners (MOLN), Enliven Therapeutics (ELV...

Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)

Holcim ( ($CH:HOLN) ) has issued an announcement. Holcim shareholders approved all proposals put forward by the Board of Directors at the 2026 Annu...

Holcim Investors Back Dividend, Governance Slate at 2026 AGM

Molecular Partners ( ($MOLN) ) has provided an update. On May 12, 2026, Molecular Partners reported first-quarter 2026 results, highlighting a stro...

Molecular Partners Advances Radio-DARPin and Immuno-Oncology Pipeline on Solid Financial Footing in Q1 2026

In a report released yesterday, Elodie Rall from J.P. Morgan maintained a Buy rating on Holcim. The company’s shares closed last Friday at CHF75.22...

J.P. Morgan Remains a Buy on Holcim (0QKY)

Pollen Street Group Limited ( ($GB:POLN) ) has shared an update. Pollen Street Group Limited disclosed that its Chief Financial Officer, Crispin Go...

Pollen Street CFO boosts stake via dividend reinvestment plan

Analysts fell to the sidelines weighing in on Olin (OLN) and AdvanSix (ASIX) with neutral ratings, indicating that the experts are neither bullish ...

Analysts Are Neutral on These Materials Stocks: Olin (OLN), AdvanSix (ASIX)

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Olin (OLN), Orica Limited (OCLDF) and Freeport-McMo...

Analysts Offer Insights on Materials Companies: Olin (OLN), Orica Limited (OtherOCLDF) and Freeport-McMoRan (FCX)

Pollen Street Group Limited ( ($GB:POLN) ) just unveiled an announcement. Pollen Street Group Limited disclosed that its Chief Financial Officer, C...

Pollen Street CFO Increases Stake via Dividend Reinvestment Plan

Erste Group analyst Hans Engel maintained a Hold rating on Holcim yesterday. The company’s shares closed yesterday at CHF70.76. According to TipRan...

Erste Group Sticks to Its Hold Rating for Holcim (0QKY)

Pollen Street Group Limited ( ($GB:POLN) ) just unveiled an update. Pollen Street Group Limited has reported that, as of 30 April 2026, it has 59,5...

Pollen Street Group Updates Market on Total Voting Rights and Share Capital

UBS analyst Julian Radlinger maintained a Buy rating on Holcim today and set a price target of CHF93.00. According to TipRanks, Radlinger is a 2-st...

Holcim (0QKY) Gets a Buy from UBS

An announcement from Pollen Street Group Limited ( ($GB:POLN) ) is now available. Pollen Street Group Limited disclosed a transaction under its HMR...

Pollen Street CFO adds shares under all-employee incentive plan

UBS analyst Julian Radlinger maintained a Buy rating on Holcim today and set a price target of CHF93.00. According to TipRanks, Radlinger is ranked...

UBS Reaffirms Their Buy Rating on Holcim (0QKY)

In a report released on April 24, Anthony Codling from RBC Capital maintained a Hold rating on Holcim, with a price target of CHF74.00. The company...

RBC Capital Reaffirms Their Hold Rating on Holcim (0QKY)

Barclays analyst Tom Zhang maintained a Buy rating on Holcim on April 24 and set a price target of CHF87.00. The company’s shares closed last Frida...

Current Quarter	$0.08	Next Quarter	$0.2
Current Year	$-0.28	Next Year	$0.65
QoQ Growth	+150.0%	YoY Growth	+332.1%
3Y EPS CAGR	-100.0%	Target Price	$30.44
Consensus	Buy	Upside	+16.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	OLN	$26.13	+0.38%	1.55M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	OLN	$26.13	+0.4%	1.55M
3
4
5
6

OLN

OLN

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Olin Corporation Data in Excel

Get Olin Corporation Data in Excel